INDV
Price
$36.21
Change
+$0.05 (+0.14%)
Updated
Dec 26 closing price
Capitalization
4.53B
47 days until earnings call
Intraday BUY SELL Signals
MKKGY
Price
$28.51
Change
+$0.06 (+0.21%)
Updated
Dec 26 closing price
Capitalization
61.82B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INDV vs MKKGY

Header iconINDV vs MKKGY Comparison
Open Charts INDV vs MKKGYBanner chart's image
Indivior
Price$36.21
Change+$0.05 (+0.14%)
Volume$941.38K
Capitalization4.53B
Merck KGaA
Price$28.51
Change+$0.06 (+0.21%)
Volume$80.97K
Capitalization61.82B
INDV vs MKKGY Comparison Chart in %
INDV
Daily Signal:
Gain/Loss:
MKKGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INDV vs. MKKGY commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Buy and MKKGY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (INDV: $36.21 vs. MKKGY: $28.51)
Brand notoriety: INDV and MKKGY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INDV: 34% vs. MKKGY: 55%
Market capitalization -- INDV: $4.53B vs. MKKGY: $61.82B
INDV [@Pharmaceuticals: Generic] is valued at $4.53B. MKKGY’s [@Pharmaceuticals: Generic] market capitalization is $61.82B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 1 FA rating(s) are green whileMKKGY’s FA Score has 1 green FA rating(s).

  • INDV’s FA Score: 1 green, 4 red.
  • MKKGY’s FA Score: 1 green, 4 red.
According to our system of comparison, INDV is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 3 TA indicator(s) are bullish while MKKGY’s TA Score has 7 bullish TA indicator(s).

  • INDV’s TA Score: 3 bullish, 5 bearish.
  • MKKGY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, MKKGY is a better buy in the short-term than INDV.

Price Growth

INDV (@Pharmaceuticals: Generic) experienced а +2.84% price change this week, while MKKGY (@Pharmaceuticals: Generic) price change was +2.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.01%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +23.01%.

Reported Earning Dates

INDV is expected to report earnings on Feb 12, 2026.

MKKGY is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($61.8B) has a higher market cap than INDV($4.53B). INDV has higher P/E ratio than MKKGY: INDV (36.95) vs MKKGY (17.77). INDV YTD gains are higher at: 191.311 vs. MKKGY (1.361). MKKGY has higher annual earnings (EBITDA): 6B vs. INDV (267M). MKKGY has more cash in the bank: 2.92B vs. INDV (445M). INDV has less debt than MKKGY: INDV (356M) vs MKKGY (12.1B). MKKGY has higher revenues than INDV: MKKGY (21.3B) vs INDV (1.18B).
INDVMKKGYINDV / MKKGY
Capitalization4.53B61.8B7%
EBITDA267M6B4%
Gain YTD191.3111.36114,056%
P/E Ratio36.9517.77208%
Revenue1.18B21.3B6%
Total Cash445M2.92B15%
Total Debt356M12.1B3%
FUNDAMENTALS RATINGS
INDV vs MKKGY: Fundamental Ratings
INDV
MKKGY
OUTLOOK RATING
1..100
6029
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
6369
PRICE GROWTH RATING
1..100
3548
P/E GROWTH RATING
1..100
10077
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (28) in the null industry is significantly better than the same rating for INDV (94). This means that MKKGY’s stock grew significantly faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for MKKGY (100). This means that INDV’s stock grew significantly faster than MKKGY’s over the last 12 months.

INDV's SMR Rating (63) in the null industry is in the same range as MKKGY (69). This means that INDV’s stock grew similarly to MKKGY’s over the last 12 months.

INDV's Price Growth Rating (35) in the null industry is in the same range as MKKGY (48). This means that INDV’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (77) in the null industry is in the same range as INDV (100). This means that MKKGY’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVMKKGY
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 19 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signal:
Gain/Loss:
MKKGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UEMPX10.340.06
+0.58%
UBS Emerging Markets Equity Opp P
AVEGX52.250.13
+0.25%
Ave Maria Growth
CSMMX20.74-0.02
-0.10%
Invesco Summit C
MEICX49.80-0.05
-0.10%
MFS Value C
BGLCX11.42-3.25
-22.15%
Brookfield Global Listed InfrastructureC

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+0.14%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
+0.42%
ALKS - INDV
25%
Poorly correlated
-0.11%
MKKGY - INDV
24%
Poorly correlated
+0.21%
EOLS - INDV
23%
Poorly correlated
+0.73%
More

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+0.21%
MKGAF - MKKGY
49%
Loosely correlated
+2.59%
AMPH - MKKGY
25%
Poorly correlated
+1.16%
ZTS - MKKGY
25%
Poorly correlated
+0.59%
SUPN - MKKGY
25%
Poorly correlated
-0.39%
INDV - MKKGY
24%
Poorly correlated
+0.14%
More